Hinge Health (HNGE) Cash from Financing Activities (2024 - 2026)

Hinge Health has disclosed Cash from Financing Activities across 3 years of filings, most recently posting -$30.5 million for Q2 2026.

• In Q2 2026, Cash from Financing Activities rose 59.66% year-over-year to -$30.5 million; the TTM figure through Jun 2026 stood at -$222.3 million (down 201.24% YoY), while the FY2025 annual figure was -$150.5 million, down 6733.24% from the prior year.
• Cash from Financing Activities came in at -$30.5 million for Q2 2026 at Hinge Health, up from -$112.8 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $4.1 million in Q1 2025 to a low of -$112.8 million in Q1 2026.
• Average Cash from Financing Activities over 3 years is -$37.0 million, with a median of -$16.4 million recorded in 2024.
• The largest YoY upside for Cash from Financing Activities was 2894.74% in 2025 against a maximum downside of 3306.64% in 2025.
• Over 3 years, Cash from Financing Activities stood at -$2.3 million in 2024, then sank by 3306.64% to -$79.5 million in 2025, then jumped by 61.68% to -$30.5 million in 2026.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were -$30.5 million in Q2 2026, -$112.8 million in Q1 2026, and -$79.5 million in Q4 2025.